I N G R E D I E N T S www.foodtechnology.co.nz 25 • Flavour specialists and designers • Liquid and powder flavour manufacture • Naturals • New Zealand made Formula Foods Corporation Limited Phone 64 3 962 2960 www.formulafoods.co.nz FT171 CEREAL NEWS: A new fungicide for wheat and barley described as a critical new tool to control speckled leaf blotch and scald has been launched by Nelson-based ADAMA New Zealand. Phoenix, which offers unique multi-site protectant chemistry specifically to keep resistance at bay in cereal crops, has been highly anticipated by Kiwi cereal growers. Leaf blotch is a yield-decimating disease identified as resistant to Qol fungicides here in 2013, resulting in two or three tonnes of losses per hectare in the 2013-14 season. The new fungicide works against the disease at a cellular level using a multi-site mode of action to inhibit both spore germination and cell division, reducing energy production in the mitochondria. SOLAR BROWNIES: A New York bakery has begun baking sweet solar sustenance, thanks to a $US33,000, 8.82 kilowatt solar array donated by Green Mountain Energy that uses extra power from its residential customers. Greyston Bakery, which supports a non-profit organisation called Greyston Foundation, has been supported by the energy company’s Sun Club, which provides solar power and educational information to charities. The array, made up of 36 solar panels on the roof of the bakery, will generate 10,000 kilowatt-hours of pollution-free energy and avoid 11,800 pounds of carbon dioxide each year. “Just when I thought our brownies couldn’t get any better, we’re now using a clean source of energy to bake them, thanks to the Sun Club,” Greyston Bakery chief executive Mike Brady says. ON THE WINGS OF ANGELS: A Kiwi food innovation company is included in equity crowdfunding requests on AngelEquity, a new online platform offering wholesale investors the opportunity to invest in Kiwi start-ups alongside seasoned angel investors. Quantec is an agritech company taking its patented discovery of a novel milk protein and developing applications in human and animal health, including: the world’s first non-antibiotic nil-milk withhold treatments for mastitis in dairy cows, a problem that carries a $1.5 billion cost worldwide; an IDP milk protein for use in supplements and oral care applications where consumers are seeking naturally-derived alternatives to synthetic active ingredients; and IDP for use in skincare for conditions such as acne and eczema. The company, valued at $9 million, needs $750,000 in crowd funding. www.angelequity.co.nz
FT-Oct16
To see the actual publication please follow the link above